CClinicalTrials.gg
Status unknownNCT05691920Updated Jan 25, 2023

Regional Blocks for CABG Artery Bypass Graft Surgery

A Phase 3 interventional study of Pectointercostal plane block and external oblique intercostal plane block and Fentanyl infusion in Analgesia After Coronary Artery Bypass Graft Surgery, sponsored by Alexandria University. Status unknown. Per ClinicalTrials.gov, last updated 2023-01-25.

Sponsored by Alexandria University · Phase 3, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Nov 2022), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Phase 3
Study type
Interventional
Enrollment
120
Allocation
Randomized
Sex
All
01

Study summary

Pain control after CABG is an essential step to guard against postoperative complications such as lung atelectasis. This major step can be achieved by opioids or regional blocks.

Regional blocks allow better pain control and avoid side effects of opioid based pain control

Read the detailed description

Ultrasound guided External oblique intercostal plane block and pectointercostal plane block for perioperative analgesia in coronary artery bypass graft surgery: Prospective randomized controlled study

Introduction:

Pain control is a vital component to achieve enhanced recovery after cardiac surgery. Effective postoperative pain control will reduce the incidence of numerous postoperative complications, can facilitate early mobilization and may result in earlier recovery.

Pain control is historically achieved by the administration of opioids, which is associated with well-documented side effects, such as sedation, respiratory depression, pruritus, hallucinations and postoperative nausea and vomiting (PONV). Enhanced recovery following coronary artery bypass grafting (CABG) has gained attention even though there is limited evidence on the efficacy and effectiveness of existing analgesic techniques.

The external oblique intercostal plane and pectointercostal plane blocks are a new modality that will be used to improve pain-related outcomes after CABG surgery, and has not been extensively investigated. Therefore, we will test the hypothesis that external oblique intercostal plane and pectointercostal plane blocks can reduce cumulative opioid consumption for the patients undergoing CABG surgery when added to conventional multi-model intravenous analgesic technique.

The aim of this prospective comparative investigation is to assess the impact of external oblique intercostal plane and pectointercostal plane blocks in a multimodal perioperative analgesic regimen and any related side effects in patients undergoing CABG surgery.

Patients and Methods:

A prospective study will be carried out in Alexandria Main University Hospital on 120 American society of anaesthesiologists (ASA) II, III physical status aged 40-60 years scheduled for major upper abdominal surgery, after approval of the Medical Ethics Committee and an informed written consent. Patients will be categorized into two equal groups, group I (60) will be subjected to bilateral external oblique intercostal plane and pectointercostal plane blocks and group II (60) will be subjected to fentanyl infusion at a rate of 1μg/kg/h. During the patient stay in the ICU, total analgesic requirements will be measured in both groups. Also, sedation level, duration of intubation and length of ICU stay will be assessed.

02

Conditions studied

  • Analgesia After Coronary Artery Bypass Graft Surgery
03

In context

Lead sponsor

Alexandria University is the lead sponsor of 569 studies on the registry; 125 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • patients undergoing CABG surgery

Exclusion criteria

Exclusion Criteria:

  • BMI above 40
  • allergy for drugs used
  • complicated cases
  • patient refusal
  • chronic opioid use
  • cognitive dysfunction
  • chronic kidney disease
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
120 participants (estimated)

Study arms

  • Active comparator
    Block group

    Patients will be subjected to bilateral external oblique intercostal plane and pectointercostal plane blocks

    Procedure: Pectointercostal plane block and external oblique intercostal plane block

  • Active comparator
    Opioid group

    Patients will be subjected to fentanyl infusion at a rate of 1μg/kg/h

    Procedure: Fentanyl infusion

Interventions

  • ProcedurePectointercostal plane block and external oblique intercostal plane block

    Patients will be subjected to bilateral external oblique intercostal plane and pectointercostal plane blocks

  • ProcedureFentanyl infusion

    Patients will be subjected to fentanyl infusion at a rate of 1μg/kg/h

06

What researchers measure

Primary outcomes

  1. Postoperative fentanyl requirements for 24 hours

    Visual analogue score will be measured every 2 hours

    Time frame: 24 hours postoperatively

Secondary outcomes

  1. Visual analogue score

    Visual analogue score will be measured every 2 hours

    Time frame: 24 hours postoperatively

  2. Rescue analgesia

    0.5 microgram/kg fentanyl will be given if visual analogue score more than 4

    Time frame: 24 hours postoperatively

  3. Side effects

    Any side effect related to fentanyl or block technique will be detected and treated properly

    Time frame: 24 hours postoperatively

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Engelman DT, Ben Ali W, Williams JB, Perrault LP, Reddy VS, Arora RC, Roselli EE, Khoynezhad A, Gerdisch M, Levy JH, Lobdell K, Fletcher N, Kirsch M, Nelson G, Engelman RM, Gregory AJ, Boyle EM. Guidelines for Perioperative Care in Cardiac Surgery: Enhanced Recovery After Surgery Society Recommendations. JAMA Surg. 2019 Aug 1;154(8):755-766. doi: 10.1001/jamasurg.2019.1153. PubMed 31054241 ↗

Individual participant data

Plan to share: Yes — Data will be shared on request

Supporting information: Study protocol, Csr

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 25, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05691920
Lead sponsor
Alexandria University
Responsible party
Sponsor
First posted
Jan 20, 2023
Start date
Feb 1, 2023 (estimated)
Primary completion
Jul 1, 2023 (estimated)
Completion
Jul 1, 2023 (estimated)
Last update
Jan 25, 2023

Study contacts

Mohamed Abdelmawla, MD
Contact
M_abdelmawla12@alexmed.edu.eg
+201114748411
Maha Ghanem, MD
Contact
Ghanemmaha@yahoo.com
+20127498435

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion